Literature DB >> 24437729

Inhibitory effect of selenoprotein P on Cu(+)/Cu(2+)-induced Aβ42 aggregation and toxicity.

Xiubo Du1, Zhi Wang, Youbiao Zheng, Haiping Li, Jiazuan Ni, Qiong Liu.   

Abstract

It has been suggested that the aggregation and cytotoxicity of amyloid-β (Aβ) peptide with transition-metal ions in neuronal cells is involved in the progression of Alzheimer's disease (AD). Selenoproteins are a group of special proteins that contain the 21st amino acid selenocysteine in their sequence, and they are found to be involved in the onset and progression of AD. Here, we report that the histidine-rich domain of selenoprotein P (SelP-H) is capable of binding Cu ions in both oxidation states of Cu(+) and Cu(2+) with high affinity and of modulating Cu(+) and Cu(2+)-mediated Aβ aggregation, reactive oxygen species (ROS) production, and neurotoxicity. SelP-H was found to coordinate 1 and 2 mol equiv of Cu(+) and Cu(2+) with sub-picomolar and nanomolar affinities, respectively. Cu(+)/Cu(2+) binding to Aβ42 inhibited the fibrillization of Aβ42 but induced it to form amorphous aggregates, which could be significantly restored by SelP-H, as observed by thioflavin T fluorescence and transmission electron microscopy. Interestingly, SelP-H inhibited Cu(+)/Cu(2+)-Aβ42-induced neurotoxicity and the intracellular ROS production in living cells. These studies suggest that SelP may play certain roles in regulating redox balance as well as metal homeostasis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24437729     DOI: 10.1021/ic4028282

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  8 in total

1.  Iron is a specific cofactor for distinct oxidation- and aggregation-dependent Aβ toxicity mechanisms in a Drosophila model.

Authors:  Stanislav Ott; Nikolas Dziadulewicz; Damian C Crowther
Journal:  Dis Model Mech       Date:  2015-04-23       Impact factor: 5.758

2.  Cu(II) enhances the effect of Alzheimer's amyloid-β peptide on microglial activation.

Authors:  Fengxiang Yu; Ping Gong; Zhuqin Hu; Yu Qiu; Yongyao Cui; Xiaoling Gao; Hongzhuan Chen; Juan Li
Journal:  J Neuroinflammation       Date:  2015-06-24       Impact factor: 8.322

3.  Se-methylselenocysteine inhibits apoptosis induced by clusterin knockdown in neuroblastoma N2a and SH-SY5Y cell lines.

Authors:  Chao Wang; Zhenyu Zeng; Qiong Liu; Renli Zhang; Jiazuan Ni
Journal:  Int J Mol Sci       Date:  2014-11-18       Impact factor: 5.923

Review 4.  Treatment strategies in Alzheimer's disease: a review with focus on selenium supplementation.

Authors:  Jan Aaseth; Jan Alexander; Geir Bjørklund; Knut Hestad; Petr Dusek; Per M Roos; Urban Alehagen
Journal:  Biometals       Date:  2016-08-16       Impact factor: 2.949

5.  Redox-Dependent Copper Ion Modulation of Amyloid-β (1-42) Aggregation In Vitro.

Authors:  Nima Sasanian; David Bernson; Istvan Horvath; Pernilla Wittung-Stafshede; Elin K Esbjörner
Journal:  Biomolecules       Date:  2020-06-18

Review 6.  Microglia and Astrocytes in Alzheimer's Disease in the Context of the Aberrant Copper Homeostasis Hypothesis.

Authors:  Amit Pal; Isha Rani; Anil Pawar; Mario Picozza; Mauro Rongioletti; Rosanna Squitti
Journal:  Biomolecules       Date:  2021-10-28

7.  Direct interaction between selenoprotein P and tubulin.

Authors:  Xiubo Du; Shi Qiu; Zhi Wang; Ruoran Wang; Chao Wang; Jing Tian; Qiong Liu
Journal:  Int J Mol Sci       Date:  2014-06-06       Impact factor: 5.923

Review 8.  Selenium in the Therapy of Neurological Diseases. Where is it Going?

Authors:  Agnieszka Dominiak; Anna Wilkaniec; Piotr Wroczyński; Agata Adamczyk
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.